TY - JOUR T1 - Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19 pneumonia JF - medRxiv DO - 10.1101/2020.10.15.20213058 SP - 2020.10.15.20213058 AU - Ghufran Aref Saeed AU - Waqar Gaba AU - Asad Shah AU - Abeer Ahmed Al Helali AU - Emadullah Raidullah AU - Ameirah Bader Al Ali AU - Mohammed Elghazali AU - Deena Yousef Ahmed AU - Shaikha Ghanam Al Kaabi AU - Safaa Almazrouei Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/20/2020.10.15.20213058.abstract N2 - Purpose Our aim is to correlate the clinical condition of patients with COVID-19 infection with the 25 Point CT severity score by Chang et al (devised for assessment of ARDS in patients with SARS in 2005).Material and Methods Data of consecutive symptomatic patients who were suspected to have COVID-19 infection and presented to our hospital, was collected from March to April 2020. All patients underwent two consecutive RT-PCR tests and had a non-contrast HRCT scan done at presentation. From the original cohort of 1062 patients, 160 patients were excluded leaving a total number of 902 patients.Results The mean age was 44.2 ±11.9 years [85.3%males, 14.7%females]. CT severity score found to be positively correlated with lymphopenia, increased serum CRP, d-dimer and ferritin levels (p < 0.0001). The oxygen requirements as well as length of hospital stay were increasing with the increase of scan severity.Conclusion The 25-point CT severity score correlates well with the COVID-19 clinical severity. Our data suggest that chest CT scoring system can aid in predicting COVID-19 disease outcome and significantly correlates with lab tests and oxygen requirements.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a retrospective studyFunding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board (IRB) and Department of health (DOH), Abu Dhabi, United Arab Emirates (UAE)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon requestCOVID-19coronavirus diseaseCRPC-reactive proteinCTcomputed tomographyGGOground-glass opacityHRCThigh-resolution computed tomographyPACSpicture archiving and communication systemsRT-PCRreverse transcription polymerase chain reactionWHOWorld Health Organization ER -